Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs iShares MSCI Indonesia ETF (EIDO) Price & Performance

Dolby Laboratories, Inc.Trade
iShares MSCI Indonesia ETFTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs iShares MSCI Indonesia ETF — how do they compare? Dolby Laboratories, Inc. trades at $58.63 (market cap $5.47B), while iShares MSCI Indonesia ETF trades at $11.98 (market cap $409.22M). The key difference: Dolby Laboratories, Inc. is far larger — about 13.4× iShares MSCI Indonesia ETF's market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while iShares MSCI Indonesia ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and iShares MSCI Indonesia ETF for 76 Days on average.

DLBEIDO
Market Cap
$5.47B$409.22M
Volume
1,058,284879,527
Sector
Technology—
52-Week High
$70.09$19.22
52-Week Low
$48.51$10.80
Typical Hold Time
98 Days76 Days
Enterprise Value
$4.85B—
Dividend Yield
2.46%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

DLB trades at $58.74, up 0.67% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue has been stable around $1.3B, with a net income margin of 18.9% in 2025. Recent news highlights expansion of Dolby Atmos and Vision with Meta and a leadership transition to Marc Whitten.

The outlook is mixed, with a consensus analyst price target of $90.33 suggesting significant upside, but technical indicators and a projected net cash flow decline in 2026 pose risks. Investment opportunities lie in the company's high gross margins and strategic partnerships, while risks include execution challenges and market volatility.

iShares MSCI Indonesia ETF

EIDO trades at $11.87, showing minimal daily movement with a 0.08% gain. Technical indicators signal a bearish trend, with moving averages and ADX pointing downward, though RSI levels hint at potential oversold conditions. Recent news highlights underperformance amid sector rotation away from Asian equities, with volume declining 21% below average. Key financial ratios are unavailable in the provided data, limiting fundamental assessment.

The outlook remains cautious due to weak price action and bearish technicals. Risks include high financials exposure and slow EPS growth. Upside may depend on seasonal trends or valuation support, but current sentiment and institutional flows suggest continued pressure. Investors should weigh technical weakness against potential bargain opportunities.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

EIDO
92% Buy8% Sell
Avg holding period · 76 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About iShares MSCI Indonesia ETF

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.

Read more on EIDO →